189 related articles for article (PubMed ID: 25324169)
1. High expression of transcriptional factor HoxB9 predicts poor prognosis in patients with lung adenocarcinoma.
Zhan J; Wang P; Niu M; Wang Y; Zhu X; Guo Y; Zhang H
Histopathology; 2015 Jun; 66(7):955-65. PubMed ID: 25324169
[TBL] [Abstract][Full Text] [Related]
2. Elevated HOXB9 expression promotes differentiation and predicts a favourable outcome in colon adenocarcinoma patients.
Zhan J; Niu M; Wang P; Zhu X; Li S; Song J; He H; Wang Y; Xue L; Fang W; Zhang H
Br J Cancer; 2014 Aug; 111(5):883-93. PubMed ID: 25025961
[TBL] [Abstract][Full Text] [Related]
3. PCAF-mediated acetylation of transcriptional factor HOXB9 suppresses lung adenocarcinoma progression by targeting oncogenic protein JMJD6.
Wan J; Xu W; Zhan J; Ma J; Li X; Xie Y; Wang J; Zhu WG; Luo J; Zhang H
Nucleic Acids Res; 2016 Dec; 44(22):10662-10675. PubMed ID: 27613418
[TBL] [Abstract][Full Text] [Related]
4. HOXB9 promotes endometrial cancer progression by targeting E2F3.
Wan J; Liu H; Feng Q; Liu J; Ming L
Cell Death Dis; 2018 May; 9(5):509. PubMed ID: 29724991
[TBL] [Abstract][Full Text] [Related]
5. HOXB9 enhances the ability of lung cancer cells to penetrate the blood-brain barrier.
Zheng H; Li C; Li Z; Zhu K; Bao H; Xiong J; Liang P
Aging (Albany NY); 2020 Dec; 13(4):4999-5019. PubMed ID: 33411683
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas.
Wang J; Zou K; Feng X; Chen M; Li C; Tang R; Xuan Y; Luo M; Chen W; Qiu H; Qin G; Li Y; Zhang C; Xiao B; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
Mol Cancer; 2017 Oct; 16(1):158. PubMed ID: 29025423
[TBL] [Abstract][Full Text] [Related]
7. GalNAc-T14 promotes metastasis through Wnt dependent HOXB9 expression in lung adenocarcinoma.
Kwon OS; Oh E; Park JR; Lee JS; Bae GY; Koo JH; Kim H; Choi YL; Choi YS; Kim J; Cha HJ
Oncotarget; 2015 Dec; 6(39):41916-28. PubMed ID: 26544896
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of RCC2 Enhances Cell Motility and Promotes Tumor Metastasis in Lung Adenocarcinoma by Inducing Epithelial-Mesenchymal Transition.
Pang B; Wu N; Guan R; Pang L; Li X; Li S; Tang L; Guo Y; Chen J; Sun D; Sun H; Dai J; Bai J; Ji G; Liu P; Liu A; Wang Q; Xiao S; Fu S; Jin Y
Clin Cancer Res; 2017 Sep; 23(18):5598-5610. PubMed ID: 28606921
[No Abstract] [Full Text] [Related]
9. USP22 promotes tumor progression and induces epithelial-mesenchymal transition in lung adenocarcinoma.
Hu J; Yang D; Zhang H; Liu W; Zhao Y; Lu H; Meng Q; Pang H; Chen X; Liu Y; Cai L
Lung Cancer; 2015 Jun; 88(3):239-45. PubMed ID: 25907317
[TBL] [Abstract][Full Text] [Related]
10. High expression of E-cadherin in pleural effusion cells predicts better prognosis in lung adenocarcinoma patients.
Zhao C; Li X; Su C; Li J; Cheng N; Ren S; Chen X; Zhou C
Int J Clin Exp Pathol; 2015; 8(3):3104-9. PubMed ID: 26045824
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of SIX3 is associated with clinical outcome in lung adenocarcinoma.
Mo ML; Okamoto J; Chen Z; Hirata T; Mikami I; Bosco-Clément G; Li H; Zhou HM; Jablons DM; He B
PLoS One; 2013; 8(8):e71816. PubMed ID: 23977152
[TBL] [Abstract][Full Text] [Related]
12. α1-antitrypsin promotes lung adenocarcinoma metastasis through upregulating fibronectin expression.
Li Y; Miao L; Yu M; Shi M; Wang Y; Yang J; Xiao Y; Cai H
Int J Oncol; 2017 Jun; 50(6):1955-1964. PubMed ID: 28440399
[TBL] [Abstract][Full Text] [Related]
13. Elevated nuclear CCND1 expression confers an unfavorable prognosis for early stage lung adenocarcinoma patients.
Xu P; Zhao M; Liu Z; Liu Y; Chen Y; Luo R; Fang W
Int J Clin Exp Pathol; 2015; 8(12):15887-94. PubMed ID: 26884860
[TBL] [Abstract][Full Text] [Related]
14. TWIST1 upregulates miR-214 to promote epithelial-to-mesenchymal transition and metastasis in lung adenocarcinoma.
Liu C; Luo J; Zhao YT; Wang ZY; Zhou J; Huang S; Huang JN; Long HX; Zhu B
Int J Mol Med; 2018 Jul; 42(1):461-470. PubMed ID: 29693173
[TBL] [Abstract][Full Text] [Related]
15.
Martinou E; Moller-Levet C; Karamanis D; Bagwan I; Angelidi AM
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216396
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of HOXB9 is related to poor overall survival in patients with gastric carcinoma.
Sha S; Gu Y; Xu B; Hu H; Yang Y; Kong X; Wu K
Dig Liver Dis; 2013 May; 45(5):422-9. PubMed ID: 23332081
[TBL] [Abstract][Full Text] [Related]
17. Elevated MACC1 expression predicts poor prognosis in small invasive lung adenocarcinoma.
Guo T; Zhao S; Li Z; Li F; Li J; Gu C
Cancer Biomark; 2018; 22(2):301-310. PubMed ID: 29630522
[TBL] [Abstract][Full Text] [Related]
18. HOXB9 induction of mesenchymal-to-epithelial transition in gastric carcinoma is negatively regulated by its hexapeptide motif.
Chang Q; Zhang L; He C; Zhang B; Zhang J; Liu B; Zeng N; Zhu Z
Oncotarget; 2015 Dec; 6(40):42838-53. PubMed ID: 26536658
[TBL] [Abstract][Full Text] [Related]
19. Huntingtin-Interacting Protein-1 Is an Early-Stage Prognostic Biomarker of Lung Adenocarcinoma and Suppresses Metastasis via Akt-mediated Epithelial-Mesenchymal Transition.
Hsu CY; Lin CH; Jan YH; Su CY; Yao YC; Cheng HC; Hsu TI; Wang PS; Su WP; Yang CJ; Huang MS; Calkins MJ; Hsiao M; Lu PJ
Am J Respir Crit Care Med; 2016 Apr; 193(8):869-80. PubMed ID: 26595459
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of SIX1 is an independent prognostic marker in stage I-III colorectal cancer.
Kahlert C; Lerbs T; Pecqueux M; Herpel E; Hoffmeister M; Jansen L; Brenner H; Chang-Claude J; Bläker H; Kloor M; Roth W; Pilarsky C; Rahbari NN; Schölch S; Bork U; Reissfelder C; Weitz J; Aust D; Koch M
Int J Cancer; 2015 Nov; 137(9):2104-13. PubMed ID: 25951369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]